JP4941551B2 - 有機物質検出デバイス及びその製造方法 - Google Patents
有機物質検出デバイス及びその製造方法 Download PDFInfo
- Publication number
- JP4941551B2 JP4941551B2 JP2009508700A JP2009508700A JP4941551B2 JP 4941551 B2 JP4941551 B2 JP 4941551B2 JP 2009508700 A JP2009508700 A JP 2009508700A JP 2009508700 A JP2009508700 A JP 2009508700A JP 4941551 B2 JP4941551 B2 JP 4941551B2
- Authority
- JP
- Japan
- Prior art keywords
- molecular probe
- substrate
- working electrode
- gold
- organic substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title claims description 24
- 239000000126 substance Substances 0.000 title claims description 23
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000003068 molecular probe Substances 0.000 claims description 114
- 239000010931 gold Substances 0.000 claims description 99
- 229910052737 gold Inorganic materials 0.000 claims description 90
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 87
- 239000010419 fine particle Substances 0.000 claims description 78
- 239000000758 substrate Substances 0.000 claims description 55
- 238000009826 distribution Methods 0.000 claims description 26
- 239000007850 fluorescent dye Substances 0.000 claims description 21
- 230000008859 change Effects 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 11
- 239000012488 sample solution Substances 0.000 claims description 9
- 230000005284 excitation Effects 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 239000004020 conductor Substances 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 238000000034 method Methods 0.000 description 15
- 125000004434 sulfur atom Chemical group 0.000 description 14
- 125000004429 atom Chemical group 0.000 description 12
- 230000007423 decrease Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000002070 nanowire Substances 0.000 description 9
- 239000012159 carrier gas Substances 0.000 description 8
- 230000008021 deposition Effects 0.000 description 7
- 239000007789 gas Substances 0.000 description 6
- 230000000171 quenching effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000013307 optical fiber Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 3
- 229920000831 ionic polymer Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- AKIZPWSPNKVOMT-UHFFFAOYSA-N 1-sulfanylhexan-1-ol Chemical class CCCCCC(O)S AKIZPWSPNKVOMT-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- SHGAZHPCJJPHSC-ZVCIMWCZSA-N 9-cis-retinoic acid Chemical compound OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-ZVCIMWCZSA-N 0.000 description 1
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 description 1
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960001445 alitretinoin Drugs 0.000 description 1
- LXQXZNRPTYVCNG-YPZZEJLDSA-N americium-241 Chemical compound [241Am] LXQXZNRPTYVCNG-YPZZEJLDSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 229960003679 brimonidine Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- -1 for example Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 description 1
- 229950010357 tetrodotoxin Drugs 0.000 description 1
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Powder Metallurgy (AREA)
Description
基板の主表面上に離散的に分散されて該基板に固定され、直径が0.45〜1.2nmである複数の金微粒子と、
一端が前記金微粒子に結合し、先端には、有機分子と特異的に結合する性質を持つ標的捕捉部が固定された複数の分子プローブと
を有する有機物質検出デバイスが提供される。
支持基板の上に、金とは異なる導電材料からなる作用電極を形成する工程と、
前記作用電極の表面上に、直径が0.45〜1.2nmである金微粒子を分散させて固定する工程と、
有機分子と特異的に結合する性質を持つ標的捕捉部が先端部に固定され、基部には、金と結合する結合部を有する複数の分子プローブの該基部を、前記金微粒子に結合させる工程と
を有する有機物質検出デバイスの製造方法が提供される。
1a 下地基板
1b 密着層
1c 作用電極
10 金微粒子
10a 金原子
20 分子プローブ
20a 結合部
20b 分子ワイヤ
20c 標的捕捉部
20d 蛍光色素
22 アルカンチオール
25 標的蛋白質
30 容器
31 対向電極
32 参照電極
33 電源
40 光源
41 光ファイバ
45 光検出器
46 光ファイバ
50 試料溶液
60 堆積チャンバ
61 ステージ
65 収束部
65a 静電レンズ
66 高真空部
67 真空部
70 ノズル
73 分級装置
74 荷電装置
75 微粒子発生装置
76 キャリアガス供給装置
80、81 真空ポンプ
Amax=3/(20π2L2r2×10−18)
と算出される。以下、上式の導出課程を示す。
Pmax=1/(πL2×10−18)
と表すことができるである。半径rの金微粒子10の表面に露出しているAu原子に安定して結合できる分子プローブ20の本数N(本/個)は、
N=20πr2/3
となる。ここで、金微粒子表面に露出しているAu原子の排除面積が0.1nm2であること、Au原子3個あたり1個のS原子が結合すること、及び作用電極表面による立体障害を受けることなく安定にS原子が結合できる領域は、球体表面の半分であることを仮定した。金微粒子10の分布密度の好適範囲の上限Amax(本/m2)は、
Amax=Pmax/N=3/(20π2L2r2×10−18)
と算出される。一般的には、金微粒子の半径の平均値をr(nm)、分子プローブ20の長さの平均値をL(nm)としたとき、金微粒子の分布密度(個/m2)を、
3/(20π2L2r2×10−18)
以下とすることが好ましい。
Claims (9)
- 基板の主表面上に離散的に分散されて該基板に固定され、直径が0.45〜1.2nmである複数の金微粒子と、
一端が前記金微粒子に結合し、先端には、有機分子と特異的に結合する性質を持つ標的捕捉部が固定された複数の分子プローブと
を有する有機物質検出デバイス。 - 前記金微粒子の半径の平均値をr(nm)、前記分子プローブの長さの平均値をL(nm)としたとき、金微粒子の分布密度(個/m2)が3/(20π2L2r2×10−18)以下である請求項1に記載の有機物質検出デバイス。
- 前記分子プローブは、Au−S結合により前記金微粒子に結合している請求項1または2に記載の有機物質検出デバイス。
- 前記分子プローブは、ヌクレオチド鎖を含む請求項1乃至3のいずれか1項に記載の有機物質検出デバイス。
- 前記基板は、その主表面に、金以外の導電性材料で形成された作用電極を含み、前記金微粒子は、該作用電極上に固定されている請求項1乃至4のいずれか1項に記載の有機物質検出デバイス。
- 前記分子プローブの各々の先端に、さらに蛍光色素が固定されている請求項5に記載の有機物質検出デバイス。
- さらに、
前記基板を収容すると共に、測定対象の試料溶液を収容する容器と、
前記基板に固定されている前記分子プローブに励起光を照射する光源と、
前記分子プローブの先端に固定された蛍光色素から放射される蛍光を検出する光検出器と、
前記容器に収容された試料溶液に浸漬され、前記基板上の作用電極と対をなす対向電極と、
前記容器に収容された試料溶液に基準電位を与える参照電極と、
前記参照電極に対する作用電極の電位を測定し、該作用電極の電位の符号が周期的に反転するように、前記作用電極と対向電極との間に電圧を印加する電源と
を有する請求項6に記載の有機物質検出デバイス。 - 前記電源は、前記作用電極の電位の符号が反転する周期を変化させることができる請求項7に記載の有機物質検出デバイス。
- 支持基板の上に、金とは異なる導電材料からなる作用電極を形成する工程と、
前記作用電極の表面上に、直径が0.45〜1.2nmである金微粒子を分散させて固定する工程と、
有機分子と特異的に結合する性質を持つ標的捕捉部が先端部に固定され、基部には、金と結合する結合部を有する複数の分子プローブの該基部を、前記金微粒子に結合させる工程と
を有する有機物質検出デバイスの製造方法。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2007/000349 WO2008126146A1 (ja) | 2007-03-30 | 2007-03-30 | 有機物質検出デバイス及びその製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2008126146A1 JPWO2008126146A1 (ja) | 2010-07-15 |
JP4941551B2 true JP4941551B2 (ja) | 2012-05-30 |
Family
ID=39863332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009508700A Expired - Fee Related JP4941551B2 (ja) | 2007-03-30 | 2007-03-30 | 有機物質検出デバイス及びその製造方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100068799A1 (ja) |
JP (1) | JP4941551B2 (ja) |
DE (1) | DE112007003411T5 (ja) |
WO (1) | WO2008126146A1 (ja) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006308373A (ja) * | 2005-04-27 | 2006-11-09 | Hitachi Ltd | Dna固定化fetセンサ及びその作製方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391272A (en) * | 1992-03-06 | 1995-02-21 | Andcare, Inc. | Electrochemical immunoassay methods |
US6706473B1 (en) * | 1996-12-06 | 2004-03-16 | Nanogen, Inc. | Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides |
US6306584B1 (en) * | 1997-01-21 | 2001-10-23 | President And Fellows Of Harvard College | Electronic-property probing of biological molecules at surfaces |
US6391558B1 (en) * | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
US20050148101A1 (en) * | 1999-01-23 | 2005-07-07 | Bamdad Cynthia C. | Interaction of colloid-immobilized species with species on non-colloidal structures |
CA2413932A1 (en) * | 2000-06-23 | 2002-01-03 | R. Shoshana Bamdad | Interaction of colloid-immobilized species with species on non-colloidal structures |
CA2314398A1 (en) * | 2000-08-10 | 2002-02-10 | Edward Shipwash | Microarrays and microsystems for amino acid analysis and protein sequencing |
US20040110277A1 (en) * | 2002-04-12 | 2004-06-10 | Seiko Epson Corporation | Sensor cell, bio-sensor, capacitance element manufacturing method, biological reaction detection method and genetic analytical method |
JP2005077396A (ja) * | 2003-08-28 | 2005-03-24 | Microtec Nition:Kk | 分析用光導波路 |
US20060057604A1 (en) * | 2004-03-15 | 2006-03-16 | Thinkfar Nanotechnology Corporation | Method for electrically detecting oligo-nucleotides with nano-particles |
WO2005123959A2 (en) * | 2004-06-10 | 2005-12-29 | Perkinelmer Las, Inc. | Multiplexing assays for analyte detection |
JP4585523B2 (ja) * | 2004-12-28 | 2010-11-24 | 独立行政法人科学技術振興機構 | 自己組織化材料または微粒子を基板上に固定化する方法、および当該方法を用いて作製した基板 |
JP4113545B2 (ja) | 2005-12-05 | 2008-07-09 | 富士通株式会社 | カーボンナノチューブの形成装置及び方法 |
US8288162B2 (en) * | 2006-03-28 | 2012-10-16 | Inanovate, Inc. | Nano-particle biochip substrates |
-
2007
- 2007-03-30 DE DE112007003411T patent/DE112007003411T5/de not_active Withdrawn
- 2007-03-30 WO PCT/JP2007/000349 patent/WO2008126146A1/ja active Application Filing
- 2007-03-30 JP JP2009508700A patent/JP4941551B2/ja not_active Expired - Fee Related
-
2009
- 2009-09-29 US US12/569,569 patent/US20100068799A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006308373A (ja) * | 2005-04-27 | 2006-11-09 | Hitachi Ltd | Dna固定化fetセンサ及びその作製方法 |
Also Published As
Publication number | Publication date |
---|---|
US20100068799A1 (en) | 2010-03-18 |
DE112007003411T5 (de) | 2010-01-21 |
JPWO2008126146A1 (ja) | 2010-07-15 |
WO2008126146A1 (ja) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ye et al. | Single-particle tracking with scattering-based optical microscopy | |
Park et al. | Plasmonic schirmer strip for human tear-based gouty arthritis diagnosis using surface-enhanced Raman scattering | |
JP2575270B2 (ja) | 核酸の塩基配列決定方法、単一分子検出方法、その装置及び試料の作成方法 | |
Doose et al. | Comparison of photophysical and colloidal properties of biocompatible semiconductor nanocrystals using fluorescence correlation spectroscopy | |
Cannone et al. | Quenching and blinking of fluorescence of a single dye molecule bound to gold nanoparticles | |
Zhang et al. | Metal-enhanced fluoroimmunoassay on a silver film by vapor deposition | |
Galopin et al. | Silicon nanowires coated with silver nanostructures as ultrasensitive interfaces for surface-enhanced Raman spectroscopy | |
Bjerneld et al. | Laser-induced growth and deposition of noble-metal nanoparticles for surface-enhanced Raman scattering | |
EP2710342B1 (en) | Surface enhanced raman spectroscopy sensor, system and method of sensing | |
D’Andrea et al. | SERS enhancement and field confinement in nanosensors based on self-organized gold nanowires produced by ion-beam sputtering | |
CN103512878B (zh) | 基于GO和GQDs之间ECL-RET作用的传感器制备方法及激酶检测应用 | |
US9443632B2 (en) | Hybrid device for on-chip concentration, manipulation, sorting and sensing of particles on a plasmonic substrate | |
Ando et al. | Single-nanoparticle tracking with angstrom localization precision and microsecond time resolution | |
Yu et al. | Plasma-enhanced antibody immobilization for the development of a capillary-based carcinoembryonic antigen immunosensor using laser-induced fluorescence spectroscopy | |
JP2008281530A (ja) | 表面増強振動分光分析用プローブおよびその製造方法 | |
Osborne et al. | Quantum dot photoluminescence activation and decay: dark, bright, and reversible populations in ZnS-capped CdSe nanocrystals | |
Loumaigne et al. | Ligand-induced anisotropy of the two-photon luminescence of spherical gold particles in solution unraveled at the single particle level | |
Tarpani et al. | Photoactivation of luminescent centers in single SiO2 nanoparticles | |
JP2013083639A (ja) | 被検物質の特異的検出方法 | |
CN102590168A (zh) | 基于发光二极管的荧光微生物检测仪 | |
JP5844071B2 (ja) | 検出装置および検出方法 | |
CN107589166A (zh) | 一种基于TiO2介观晶体的免标记型玉米赤霉烯酮光电化学检测方法和传感器 | |
Zhang et al. | Label-free imaging of single proteins and binding kinetics using total internal reflection-based evanescent scattering microscopy | |
Gou et al. | Site-selective heat boosting electrochemiluminescence for single cell imaging | |
JP4941551B2 (ja) | 有機物質検出デバイス及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120131 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120213 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150309 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |